Clinical Trial Update: Safety Study of Individualised Radiation Dose Determination for Lung Cancer Patients. [Phase 1]

View source ↗

Summary

Phase 1 safety study evaluating individualized radiation dose determination for non-small cell lung cancer patients; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Maastricht Radiation Oncology | Conditions: Non-Small-Cell Lung Carcinoma | Phase 1 | Status: COMPLETED